|
|
 |
|
Viewing report
|
|
|
|
Thermo Fisher to Acquire Phadia - Focus on Inorganic Growth to be a Main Strategy
GlobalData, June 2011, Pages: 8
Thermo Fisher to Acquire Phadia - Focus on Inorganic Growth to be a Main Strategy - Deal Analysis from GlobalData
Summary
GlobalData’s report, “Thermo Fisher to Acquire Phadia - Focus on Inorganic Growth to be a Main Strategy” provides key information and analysis on Thermo Fisher’s proposed acquisition of Phadia. The report provides information on deal rationale that includes key insights on the deal based on Thermo Fisher’s inorganic growth strategies.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- In-vitro diagnostics market size for 2010 and forecast forward to 2017.
- Qualitative analysis on Thermo Fisher’s acquisition of Phadia.
- Thermo Fisher’s inorganic growth strategies in recent years.
- Pipeline study of in-vitro diagnostics products of Phadia.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the In-Vitro Diagnostics market.
- Design and develop your marketing and sales strategies
- Develop market expansion strategies.
- Exploit M&A opportunities by identifying key areas of growth
|
|
|
|
